2025-07-22 - Analysis Report
Okay, here's a comprehensive analysis of Microstrategy Inc (MSTR), incorporating all the data you've provided.  The report is structured for clarity, with key numbers first, followed by analysis.

## Microstrategy Inc (MSTR) Analysis

**Ticker:** MSTR
**Company:** Microstrategy Inc.
**Description:** Microstrategy Inc. is a company that provides enterprise analytics software and services.

### 1. Performance vs. S&P 500 (VOO)

*   **MSTR Cumulative Return:** 1453.47%
*   **VOO Cumulative Return:** 97.07%
*   **Absolute Spread:** 1345.6
*   **Spread Range:** (Min: -66.9, Max: 1984.7)
*   **Relative Spread:** 68.8

**Analysis:**

MSTR has significantly outperformed the S&P 500 (VOO) over the observed period. The current absolute spread is very high. The relative spread of 68.8 indicates that the current outperformance, while substantial, is not at its historical peak relative to VOO.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
|------------|---------|-------|---------|--------|--------|
| 2015-2017  | -25.0%  | 56.6% | -54.0%  | -0.1   | 3.7    |
| 2016-2018  | -21.0%  | 62.6% | -39.0%  | -0.1   | 3.6    |
| 2017-2019  | -23.0%  | 62.6% | -53.0%  | -0.3   | 4.0    |
| 2018-2020  | 135.0%  | 62.6% | 115.0%  | -0.2   | 10.9   |
| 2019-2021  | 170.0%  | 71.0% | 121.0%  | -0.2   | 15.3   |
| 2020-2022  | 16.0%   | 72.7% | 13.0%   | -0.1   | 4.0    |
| 2021-2023  | 9.0%    | 72.7% | -9.0%   | 2.8    | 17.8   |
| 2022-2024  | 1382.0% | 72.7% | 1357.0% | 3.0    | 81.4   |
| 2023-2025  | 1382.0% | 71.3% | 1333.0% | 0.9    | 119.8  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows extremely high growth in the most recent periods (2022-2025), contrasting with negative growth in earlier periods (2015-2019).
*   **MDD:** The Maximum Drawdown indicates significant risk, with MDD values generally high across all periods, reflecting substantial volatility.
*   **Alpha:** The Alpha values are overwhelmingly positive in recent years, suggesting that MSTR has consistently outperformed the market (S&P 500) on a risk-adjusted basis.  The earlier negative Alpha values indicate underperformance during those periods.
*   **Beta:** The Beta values vary but are relatively low in most periods, except for 2021-2023 and 2022-2024, where the Beta is notably higher. This suggests that MSTR's price movements were less correlated with the market in the earlier periods but became more correlated later on. The high Betas in recent years imply that MSTR's price movements are now more sensitive to market changes.
*   **Cap(B):** The Market Capitalization has dramatically increased in recent years, indicating significant growth and investor interest.

### 2. Recent Price Action

*   **Current Price:** 426.28
*   **Previous Close:** 423.22
*   **Change:** 0.72
*   **5-day Moving Average:** 439.81
*   **20-day Moving Average:** 410.394
*   **60-day Moving Average:** 394.287

**Analysis:**

The stock price increased slightly from the previous close. The 5-day moving average is above the 20-day and 60-day moving averages, which suggests an upward trend in the short term.  However, the price is below the 5-day MA, indicating a potential short-term pullback.

### 3. Market Risk Indicator (MRI) and Other Indicators

*   **MRI:** 0.3383 (Low Risk)
*   **RSI:** 55.72
*   **PPO:** 0.3869
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **20-day Relative Spread Change:** -2.1 (Negative: Short-term decline)
*   **Expected Return:** 137.3% (Long-term, vs. S&P 500)

**Analysis:**

*   The MRI suggests a **low-risk** environment.
*   The RSI is around 55, indicating neither overbought nor oversold conditions.
*   The PPO is positive, suggesting the price is above its moving average and indicating an uptrend.
*   The Hybrid Signal is cautious, recommending buying 80% of available cash, reflecting the MRI score.
*   The negative change in the 20-day relative spread suggests that the recent outperformance relative to the S&P 500 is decreasing.
*   The high expected return (137.3%) suggests significant potential upside over the long term, relative to the S&P 500.
*   The small price change from the previous close doesn't indicate any major short-term volatility event.

### 4. Recent News & Significant Events

*   **[2025-07-20]:**  Major business developments, regulatory changes, or market events affecting MSTR.
*   **[2025-07-22]:**  Analysts discussing MSTR's performance and outlook in the context of industry trends and global economic factors.
*   **[2025-07-18]:**  Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **[2025-07-21]:**  Market experts highlighting both risks and opportunities, advising monitoring of news and announcements.

**Analysis:**

The news snippets suggest that MSTR is currently subject to market attention, volatility, and analyst scrutiny. The potential for regulatory changes and major business developments could significantly impact the stock.

### 5. Recent Earnings Analysis

| 날짜       | EPS    | 매출      |
|------------|--------|-----------|
| 2025-05-05 | -16.49 | 0.11 B$   |
| 2024-10-31 | -1.72  | 0.12 B$   |
| 2024-08-06 | -5.74  | 0.11 B$   |
| 2024-05-01 | -3.09  | 0.12 B$   |
| 2025-05-05 | -0.31  | 0.12 B$   |

**Analysis:**

*   **EPS:** The Earnings Per Share (EPS) is consistently negative across all reported quarters. The most recent EPS (-0.31) shows improvement compared to previous quarters but is still negative.
*   **Revenue:** Revenue has been relatively stable, fluctuating between $0.11 billion and $0.12 billion.

The negative EPS values indicate that Microstrategy has not been profitable in the recent quarters. However, the stable revenue suggests that the company is maintaining its sales levels. The improving EPS in the latest quarter could signal a potential turnaround, but it is important to monitor this trend in future reports.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $0.11B   | 69.41%        |
| 2024-12-31 | $0.12B   | 71.69%        |
| 2024-09-30 | $0.12B   | 70.41%        |
| 2024-06-30 | $0.11B   | 72.24%        |
| 2024-03-31 | $0.12B   | 73.96%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-03-31 | $33.53B  | -12.58%   |
| 2024-12-31 | $18.23B  | -3.68%    |
| 2024-09-30 | $3.77B   | -9.01%    |
| 2024-06-30 | $2.83B   | -3.62%    |
| 2024-03-31 | $2.40B   | -2.21%    |

**Analysis:**

*   **Revenue and Profit Margin:** Revenue has been consistent at around $0.11B to $0.12B per quarter. The profit margins are high, ranging from 69.41% to 73.96%, indicating efficient cost management relative to revenue.
*   **Capital and Profitability:** The equity has significantly increased over the past year, from $2.40B in Q1 2024 to $33.53B in Q1 2025. Despite the increase in equity, the Return on Equity (ROE) remains negative, suggesting that the company is not generating profits relative to its equity. The negative ROE values may be due to significant losses or other factors impacting profitability despite high revenue and profit margins.

### 7. Overall Conclusion

Microstrategy (MSTR) exhibits a complex picture.

*   **Positive Signals:** The stock has delivered exceptional returns compared to the S&P 500. The MRI indicates a low-risk environment. The PPO signals a potential uptrend.  High and stable profit margins.
*   **Concerning Signals:** The company reports negative EPS and ROE despite high revenue and profit margins.  The stock is volatile. Recent news suggests potential market-moving events.  Beta increased in recent years, implying that MSTR's price movements are now more sensitive to market changes.

**Recommendation:**

Given the high volatility, the negative profitability metrics, and the potential for significant news events, a cautious approach is warranted. Investors should carefully monitor company announcements, regulatory developments, and broader market trends. The recommendation to "Buy 80% of cash" from the Hybrid Signal further reinforces the need for careful risk management. A small, well-considered position might be appropriate for investors with a high-risk tolerance and a long-term investment horizon. However, investors should be prepared for significant price swings and potential downside risk.
